Literature DB >> 15385354

Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia.

Kyo S Kim1, Mi A Cheong, Hee J Lee, Jae M Lee.   

Abstract

We sought to determine whether tactile train-of-four (TOF) count can predict the efficacy of neostigmine administration for rocuronium-induced blockade during propofol or sevoflurane anesthesia, and to follow subsequent recovery until the TOF ratio reached 0.9. One-hundred-sixty patients, divided into eight equal groups, were randomly allocated to maintenance of anesthesia with propofol or sevoflurane. The tactile response of the adductor pollicis to TOF stimulation was evaluated on one arm, and the mechanomyographic response was recorded on the other. Neuromuscular block was induced with rocuronium 0.6 mg/kg and maintained with rocuronium to 15% of the control first twitch in TOF. Neostigmine 0.07 mg/kg was administered on reappearance of the first (Group I), second (Group II), third (Group III), or fourth (Group IV) tactile TOF response in each anesthesia. At this time, sevoflurane or the propofol dosage was reduced in each group (n = 20 in each group). The times from administration of neostigmine until the TOF ratio recovered to 0.7, 0.8, and 0.9 were recorded. The times [median (range)] to TOF ratio = 0.9 were 8.6 (4.7-18.9), 7.5 (3.4-9.8), 5.4 (1.6-8.6), and 4.7 (1.3-7.2) min in Groups I-IV during propofol anesthesia, respectively, and 28.6 (8.8-75.8), 22.6 (8.3-57.4), 15.6 (7.3-43.9), and 9.7 (5.1-26.4) min in corresponding groups during sevoflurane anesthesia, respectively (P < 0.0001). We recommend more than 2 TOF responses with propofol anesthesia and 4 TOF responses with sevoflurane anesthesia for adequate reversal within 10 and 15 min, respectively. The more tactile TOF responses present at the time of reversal achieved greater adequate recovery; however, tactile TOF responses are not a completely reliable predictor within a reasonable time period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385354     DOI: 10.1213/01.ANE.0000130616.57678.80

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

1.  Effectiveness of the timing principle with high-dose rocuronium during rapid sequence induction with lidocaine, remifentanil and propofol.

Authors:  Takahiro Suzuki; Mayu Aono; Naoko Fukano; Makiko Kobayashi; Shigeru Saeki; Setsuro Ogawa
Journal:  J Anesth       Date:  2010-02-26       Impact factor: 2.078

2.  Neuromuscular Block and Blocking Agents in 2018.

Authors:  Christoph Unterbuchner
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-04-01

Review 3.  Neuromuscular monitoring: an update.

Authors:  Mădălina Duţu; Robert Ivaşcu; Oana Tudorache; Darius Morlova; Alina Stanca; Silvius Negoiţă; Dan Corneci
Journal:  Rom J Anaesth Intensive Care       Date:  2018-04

Review 4.  [Algorithm-based preventive strategies for avoidance of residual neuromuscular blocks].

Authors:  C Unterbuchner; K Ehehalt; B Graf
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

5.  Monitoring of neuromuscular blockade by pulse oximetry tracing: A simple modification of mechanomyographic and acceleromyographic principles.

Authors:  Jyotirmoy Das; Sangeeta Khanna; Devalina Goswami; Pawan Kumar Kapoor; Yatin Mehta
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

6.  Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery.

Authors:  Tak Kyu Oh; Jung-Hee Ryu; Sunwoo Nam; Ah-Young Oh
Journal:  BMC Anesthesiol       Date:  2020-02-20       Impact factor: 2.217

7.  Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome.

Authors:  Thomas Ledowski; Samuel Hillyard; Brendan O'Dea; Rob Archer; Filipe Vilas-Boas; Barney Kyle
Journal:  Indian J Anaesth       Date:  2013-01

Review 8.  Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade.

Authors:  Stephan R Thilen; Sanjay M Bhananker
Journal:  Curr Anesthesiol Rep       Date:  2016-03-22

Review 9.  Neuromuscular blockade management in the critically Ill patient.

Authors:  J Ross Renew; Robert Ratzlaff; Vivian Hernandez-Torres; Sorin J Brull; Richard C Prielipp
Journal:  J Intensive Care       Date:  2020-05-24

10.  Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors.

Authors:  Thuy Luu Quang; Huyen Nguyen Thi Thu; Kinh Nguyen Quoc; Ha Nguyen Thu; Dong Pham Van; Nguyen Le Bao Tien; Vo Van Thanh; Vu Thi Nga; Chu Dinh Toi
Journal:  Open Access Maced J Med Sci       Date:  2019-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.